Daniel Duerschmied to Aged
This is a "connection" page, showing publications Daniel Duerschmied has written about Aged.
Connection Strength
0.088
-
Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial. Lancet Respir Med. 2021 07; 9(7):755-762.
Score: 0.017
-
Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein. Blood. 2021 10 07; 138(14):1269-1277.
Score: 0.004
-
Mobile ECMO retrieval of patients during the COVID-19 pandemic. Artif Organs. 2021 Oct; 45(10):1168-1172.
Score: 0.004
-
Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019. J Infect Dis. 2021 03 03; 223(5):775-784.
Score: 0.004
-
Intracerebral Hemorrhage in COVID-19 Patients with Pulmonary Failure: A Propensity Score-Matched Registry Study. Neurocrit Care. 2021 06; 34(3):739-747.
Score: 0.004
-
Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study. Artif Organs. 2021 Jun; 45(6):593-601.
Score: 0.004
-
Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients. J Thromb Thrombolysis. 2021 Jul; 52(1):76-84.
Score: 0.004
-
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19. J Thromb Thrombolysis. 2020 Oct; 50(3):558-566.
Score: 0.004
-
Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation - A Case-Control Study. J Intensive Care Med. 2021 Apr; 36(4):477-483.
Score: 0.004
-
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor? J Intern Med. 2021 01; 289(1):121-124.
Score: 0.004
-
Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience. Crit Care. 2019 Sep 18; 23(1):320.
Score: 0.004
-
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction. Am Heart J. 2019 02; 208:81-90.
Score: 0.004
-
Albumin fluid resuscitation in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy is associated with improved survival. Intensive Care Med. 2018 Dec; 44(12):2312-2314.
Score: 0.004
-
Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease. Int J Cardiol. 2019 Jan 15; 275:129-135.
Score: 0.003
-
Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction. Int J Cardiol. 2018 04 15; 257:247-254.
Score: 0.003
-
Isoflurane or propofol sedation in patients with targeted temperature management after cardiopulmonary resuscitation: A single center study. J Crit Care. 2018 06; 45:40-44.
Score: 0.003
-
Influence of low-flow time on survival after extracorporeal cardiopulmonary resuscitation (eCPR). Crit Care. 2017 Jun 22; 21(1):157.
Score: 0.003
-
Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction. Int J Cardiol. 2017 Sep 15; 243:485-491.
Score: 0.003
-
The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2019 Dec; 8(8):695-702.
Score: 0.003
-
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism. J Am Coll Cardiol. 2017 Mar 28; 69(12):1536-1544.
Score: 0.003